title: Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a).
abstract: Studies were undertaken to investigate potential interactions among plasma lipoproteins. Techniques used were low density lipoprotein2 (LDL2)-ligand blotting of plasma lipoproteins separated by nondenaturing 2.5-15% gradient gel electrophoresis, ligand binding of plasma lipoproteins by affinity chromatography with either LDL2 or lipoprotein(a) (Lp(a)) as ligands, and agarose lipoprotein electrophoresis. Ligand blotting showed that LDL2 can bind to Lp(a). When apolipoprotein(a) was removed from Lp(a) by reduction and ultracentrifugation, no interaction between LDL2 and reduced Lp(a) was detected by ligand blotting. Ligand binding showed that LDL2-Sepharose 4B columns bound plasma lipoproteins containing apolipoproteins(a), B, and other apolipoproteins. The Lp(a)-Sepharose column bound lipoproteins containing apolipoprotein B and other apolipoproteins. Furthermore, the Lp(a) ligand column bound more lipoprotein lipid than the LDL2 ligand column, with the Lp(a) ligand column having a greater affinity for triglyceride-rich lipoproteins. Lipoprotein electrophoresis of a mixture of LDL2 and Lp(a) demonstrated a single band with a mobility intermediate between that of LDL2 and Lp(a). Chemical modification of the lysine residues of apolipoprotein B (apoB) by either acetylation or acetoacetylation prevented or diminished the interaction of LDL2 with Lp(a), as shown by both agarose electrophoresis and ligand blotting using modified LDL2. Moreover, removal of the acetoacetyl group from the lysine residues of apoB by hydroxylamine reestablished the interaction of LDL2 with Lp(a). On the other hand, blocking of--SH groups of apoB by iodoacetamide failed to show any effect on the interaction between LDL2 and Lp(a). Based on these observations, it was concluded that Lp(a) interacts with LDL2 and other apoB-containing lipoproteins which are enriched in triglyceride; this interaction is due to the presence of apolipoprotein(a) and involves lysine residues of apoB interacting with the plasminogen-like domains (kringle 4) of apolipoprotein(a). Such results suggest that Lp(a) may be involved in triglyceride-rich lipoprotein metabolism, could form transient associations with apoB-containing lipoproteins in the vascular compartment, and alter the intake by the high affinity apoB, E receptor pathway.
authors.affiliation: Oklahoma Medical Research Foundation, Oklahoma City 73104.
authors.forename: S Q
authors.initials: SQ
authors.lastname: Ye
authors.forename: V N
authors.initials: VN
authors.lastname: Trieu
authors.forename: D L
authors.initials: DL
authors.lastname: Stiers
authors.forename: W J
authors.initials: WJ
authors.lastname: McConathy
mesh_terms: D001055:Apolipoproteins B / Q000378:metabolism*; D001667:Binding, Competitive; D004587:Electrophoresis, Agar Gel; D006801:Humans; D007460:Iodoacetamide / Q000494:pharmacology; D008024:Ligands / Q000378:metabolism; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008854:Microscopy, Electron
chemical_list: D001055:Apolipoproteins B; D008024:Ligands; D017270:Lipoprotein(a); D008074:Lipoproteins; D008077:Lipoproteins, LDL; D007460:Iodoacetamide